Kilitch Drugs
₹334.05
INR+5.05(+1.53%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹525.25 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹457.71 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
41.55
Forward P/E
Price to Earnings ratio based on forecasted earnings
21.35
PEG Ratio
Price/Earnings to Growth ratio
21.35
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
3.47
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
44.60%
Operating Margin
Operating income as a percentage of revenue
2.41%
Return on Equity
Net income as a percentage of shareholders' equity
8.31%
Revenue (TTM)
Total revenue over trailing 12 months
₹151.27 Cr-8.5%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹26.13 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹7.86-60.099999999999994%
Balance Sheet
Total Cash
Total cash and short-term investments
₹69.07 Cr
Total Debt
Total short-term and long-term debt
₹31.65 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
18.01%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹291.5 - ₹470
Beta
Measure of stock's volatility compared to the market
0.24
Shares Outstanding
Total number of shares issued by the company
₹1.61 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.62%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
0.00%